HWA
CBIO

HCR Wealth Advisors’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

HCR Wealth Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000
Closed -$16.9K – 232
2024
Q3 		$16.9K Buy
+1,000
New +$16.9K ﹤0.01% 229